Bernd Schnabl

31.1k total citations · 13 hit papers
217 papers, 18.0k citations indexed

About

Bernd Schnabl is a scholar working on Epidemiology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Bernd Schnabl has authored 217 papers receiving a total of 18.0k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Epidemiology, 108 papers in Molecular Biology and 70 papers in Pathology and Forensic Medicine. Recurrent topics in Bernd Schnabl's work include Liver Disease Diagnosis and Treatment (147 papers), Gut microbiota and health (83 papers) and Alcohol Consumption and Health Effects (70 papers). Bernd Schnabl is often cited by papers focused on Liver Disease Diagnosis and Treatment (147 papers), Gut microbiota and health (83 papers) and Alcohol Consumption and Health Effects (70 papers). Bernd Schnabl collaborates with scholars based in United States, Germany and Belgium. Bernd Schnabl's co-authors include David A. Brenner, Ekihiro Seki, Peter Stärkel, Phillipp Hartmann, Rohit Loomba, Katharina Brandl, Rob Knight, Derrick E. Fouts, Michael Karin and Yi Duan and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Bernd Schnabl

212 papers receiving 17.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The gut–liver axis and the intersection with the microbiome

2018 1.0k citations David A. Brenner, Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology profile →
New mitochondrial DNA synthesis enables NLRP3 inflammasome activation

2018 881 citations Bernd Schnabl, Tatiana Kisseleva et al. profile →
Interactions Between the Intestinal Microbiome and Liver Diseases

2014 743 citations Bernd Schnabl, David A. Brenner profile →
Enteric dysbiosis associated with a mouse model of alcoholic liver disease

2010 639 citations Derrick E. Fouts, Peter Stärkel et al. Hepatology profile →
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice

2010 615 citations Bernd Schnabl, David A. Brenner et al. profile →
Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits

2008 508 citations Katharina Brandl, Bernd Schnabl et al. profile →
Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis

2015 409 citations Bernd Schnabl et al. profile →
FXR Regulates Intestinal Cancer Stem Cell Proliferation

2019 331 citations Bernd Schnabl, Ruth T. Yu et al. profile →
The gut–liver axis and gut microbiota in health and liver disease

2023 322 citations Bernd Schnabl et al. profile →
Gut microbiome, liver immunology, and liver diseases

2020 303 citations Bernd Schnabl et al. profile →
Acute-on-chronic liver failure in cirrhosis

2016 295 citations Bernd Schnabl et al. profile →
The microbiota in cirrhosis and its role in hepatic decompensation

2021 143 citations Jonel Trebicka, Bernd Schnabl et al. profile →
Metabolic dysfunction–associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations

2025 25 citations Bernd Schnabl et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Bernd Schnabl

Since Specialization

Citations

This map shows the geographic impact of Bernd Schnabl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Schnabl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Schnabl more than expected).

Fields of papers citing papers by Bernd Schnabl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd Schnabl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Schnabl. The network helps show where Bernd Schnabl may publish in the future.

Co-authorship network of co-authors of Bernd Schnabl

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd Schnabl. A scholar is included among the top collaborators of Bernd Schnabl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd Schnabl. Bernd Schnabl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Activation of intestinal endogenous retroviruses by alcohol exacerbates liver disease 2025 ·Journal of Clinical Investigation ·Noemí Cabré, Marcos F. Fondevila, (unknown), Tomoo Yamazaki, Fernanda Raya Tonetti, Álvaro Eguileor, Ricard Garcia‐Carbonell, Abraham S. Meijnikman, Yukiko Miyamoto, Susan Mayo, Yanhan Wang, Xinlian Zhang, Thorsten Trimbuch, Seija Lehnardt, Lars Eckmann, Derrick E. Fouts, Cristina Llorente, Hidekazu Tsukamoto, Peter Stärkel, Bernd Schnabl	3
2	Origin, Function, and Implications of Intestinal and Hepatic Macrophages in the Pathogenesis of Alcohol-Associated Liver Disease 2025 ·Cells ·Yifan Hu, Bernd Schnabl, Peter Stärkel	1
3	Insertion sequence-mediated phage resistance contributes to attenuated colonization of cytolytic Enterococcus faecalis variants in the gut 2025 ·Microbiology Spectrum ·Jumpei Fujiki, Tomohiro Nakamura, (unknown), Cristina Llorente, Derrick E. Fouts, Bernd Schnabl	3
4	Gut Bacteria in Alcohol-Associated Liver Disease 2024 ·Clinics in Liver Disease ·Yongqiang Yang, Bernd Schnabl	7
5	Endogenous ethanol production in health and disease 2024 ·Nature Reviews Gastroenterology & Hepatology ·Abraham S. Meijnikman, Max Nieuwdorp, Bernd Schnabl	22
6	Hepatic immune regulation and sex disparities 2024 ·Nature Reviews Gastroenterology & Hepatology ·Patrizia Burra, Alberto Zanetto, Bernd Schnabl, Thomas Reiberger, Aldo J. Montaño‐Loza, Rosanna Asselta, Tom H. Karlsen, Frank Tacke	12
7	The arginine methyltransferase PRMT5 promotes mucosal defense in the intestine 2023 ·Life Science Alliance ·(unknown), Cristina Llorente, Shengyun Ma, K. Miyamoto, (unknown), (unknown), Zihui Xiao, (unknown), Elina I. Zúñiga, Pradipta Ghosh, Bernd Schnabl, Wendy Huang	4
8	Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure 2023 ·Hepatobiliary & pancreatic diseases international ·Phillipp Hartmann, Sonja Lang, Robert Schierwagen, Sabine Klein, Michael Praktiknjo, Jonel Trebicka, Bernd Schnabl	7
9	IgY antibodies against cytolysin reduce ethanol-induced liver disease in mice 2023 ·Hepatology ·Noemí Cabré, Phillipp Hartmann, Cristina Llorente, (unknown), Yanhan Wang, Su-Ling Zeng, (unknown), Xinlian Zhang, Tatiana Kisseleva, (unknown), (unknown), Bernd Schnabl	10
10	Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts 2023 ·Cellular and Molecular Gastroenterology and Hepatology ·Burcin Özdirik, Bernd Schnabl	11
11	Engineered bacteria producing aryl‐hydrocarbon receptor agonists protect against ethanol‐induced liver disease in mice 2023 ·Alcohol Clinical and Experimental Research ·(unknown), Su-Ling Zeng, Yanhan Wang, Yi Duan, Sonja Lang, Bei Gao, Phillipp Hartmann, Noemí Cabré, Cristina Llorente, Chloé Galbert, Patrick Emond, Harry Sokol, Michael J. James, Chun‐Cheih Chao, Jianrong Gao, Mylène Perreault, David L. Hava, Bernd Schnabl	27
12	Immune Response of an Oral Enterococcus faecalis Phage Cocktail in a Mouse Model of Ethanol-Induced Liver Disease 2022 ·Viruses ·Beatriz Garcia Mendes, Yi Duan, Bernd Schnabl	13
13	Selective PPARδ agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 via the fibroblast growth factor 21 signaling pathway 2022 ·Journal of Biological Chemistry ·(unknown), Xiao Liu, (unknown), Tatiana Kisseleva, Edward E. Cable, Bernd Schnabl	37
14	Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice 2022 ·Hepatology International ·Phillipp Hartmann, Yi Duan, Yukiko Miyamoto, Münevver Demir, Sonja Lang, (unknown), Patrick Stern, Dennis S. Yamashita, (unknown), Lars Eckmann, Bernd Schnabl	22
15	Roles for the mycobiome in liver disease 2022 ·Liver International ·Su-Ling Zeng, Bernd Schnabl	22
16	Integrative Analysis of Metabolome and Microbiome in Patients with Progressive Alcohol-Associated Liver Disease 2021 ·Metabolites ·Bei Gao, Yixin Zhu, Nan Gao, Weishou Shen, Peter Stärkel, Bernd Schnabl	3
17	Cytolysin‐positive Enterococcus faecalis is not increased in patients with non‐alcoholic steatohepatitis 2020 ·Liver International ·Sonja Lang, Münevver Demir, Yi Duan, Anna Martin, Bernd Schnabl	32
18	Transcriptomic Profiling Identifies Novel Hepatic and Intestinal Genes Following Chronic Plus Binge Ethanol Feeding in Mice 2020 ·Digestive Diseases and Sciences ·Lu Jiang, Huikuan Chu, Bei Gao, Sonja Lang, Yanhan Wang, Yi Duan, Bernd Schnabl	15
19	YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity 2019 ·Proceedings of the National Academy of Sciences ·Lirui Wang, Magdalena Mazagova, Chuyue Pan, Song Yang, Katharina Brandl, Jun Liu, Shannon M. Reilly, Yanhan Wang, (unknown), Rohit Loomba, Na Lu, Qinglong Guo, Jihua Liu, Ruth T. Yu, Michael Downes, Ronald M. Evans, David A. Brenner, Alan R. Saltiel, Bruce Beutler, Bernd Schnabl	29
20	X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C 2011 ·Proceedings of the National Academy of Sciences ·Owen M. Siggs, Bernd Schnabl, Bill D. Webb, Bruce Beutler	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact